Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Free Report) shares crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $5.16 and traded as high as $5.47. Bayer Aktiengesellschaft shares last traded at $5.43, with a volume of 683,003 shares.
Bayer Aktiengesellschaft Price Performance
The stock has a 50 day moving average price of $5.14 and a two-hundred day moving average price of $6.64. The company has a debt-to-equity ratio of 1.19, a quick ratio of 0.81 and a current ratio of 1.32. The company has a market capitalization of $21.34 billion, a PE ratio of -20.88 and a beta of 1.02.
Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Free Report) last issued its quarterly earnings data on Tuesday, November 12th. The company reported $0.07 EPS for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.10). The company had revenue of $10.96 billion for the quarter. Bayer Aktiengesellschaft had a negative net margin of 2.02% and a positive return on equity of 16.90%. Equities analysts forecast that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current year.
Bayer Aktiengesellschaft Company Profile
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
See Also
- Five stocks we like better than Bayer Aktiengesellschaft
- Following Congress Stock Trades
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- Using the MarketBeat Dividend Yield Calculator
- Oilfield Leader SLB: An AI Name You Need to Know
- Basic Materials Stocks Investing
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.